$184.0 Million
Image
Phreesia Inc.
Follow-On Offering
$221.3 Million
Image
Accolade, Inc
Follow-On Offering
$203.9 Million
Image
I-Mab Biopharma
Follow-On Offering
$43.0 Million
Image
Surgalign Holdings, Inc.
Follow-On Offering
$225.8 Million
Image
Seres Therapeutics, Inc.
Follow-On Offering
$216.8 Million
Image
Adverum Biotechnologies, Inc.
Follow-On Offering
$201.0 Million
Image
Cytokinetics, Incorporated
Follow-On Offering
$142.6 Million
Image
TCR2 Therapeutics
Follow-On Offering
$1.0 Billion
Image
Mirati Therapeutics, Inc.
Follow-On Offering
$517.5 Million
Image
Acceleron Pharma, Inc.
Follow-On Offering